Cervical cancer trials in China

In China 159 Also abroad 538

24 of 159 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
Where
Beijing
Age
18 years to 70 years
People
100
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07919431
No phaseNot yet taking people in China
Immunotherapy in Neuroendocrine Carcinoma of the Cervix
Where
Beijing
Age
18 years to 100 years
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07911423
No phaseNot yet taking people in China
Multi-omics Study of Cervical Neuroendocrine Carcinoma
Where
Beijing
Age
18 years to 100 years
People
120
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07879339
No phaseNot yet taking people in China
Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer
Where
Hefei
Age
18 years and over
People
580
Run by
Anhui Provincial Hospital
See details and how to joinNCT07782697
No phaseTaking people
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Where
Guangzhou, Shenzhen
Age
18 years and over
People
200
Run by
Sun Yat-sen University
See details and how to joinNCT06781151
No phaseNot yet taking people in China
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
Where
Hefei
Age
18 years to 65 years
People
50
Run by
Anhui Provincial Hospital
See details and how to joinNCT07077980
No phaseTaking people
A Cohort Study of Uterine Malignancies
Where
Hangzhou
Age
20 years to 75 years
People
6,200
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05635123
No phaseNot yet taking people in China
Patient Journey in Advanced Gynecologic Cancers
Where
Chongqing, Guangzhou, Hefei, Wuhan
Age
18 years and over
People
780
Run by
Tongji Hospital
See details and how to joinNCT07015593
No phaseTaking people
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
Where
Wuhan
Age
20 years to 60 years
People
10,000
Run by
Zhongnan Hospital
See details and how to joinNCT06082765
No phaseEnrolling by invitation
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Where
Wuhan
Age
18 years to 75 years
People
20
Run by
Ding Ma
See details and how to joinNCT06810895
No phaseNot yet taking people in China
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
Where
Hangzhou
Age
26 years to 54 years
People
800
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT06713655
No phaseTaking people
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
Where
Fuzhou
Age
18 years to 80 years
People
200
Run by
Fujian Cancer Hospital
See details and how to joinNCT06140589
No phaseNot yet taking people in China
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Where
Suzhou
Age
18 years to 80 years
People
80
Run by
Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06283875
No phaseTaking people
Spectral CT in Radiotherapy for Cervical Cancer
Where
Beijing
Age
18 years and over
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06433817
No phaseTaking people
a Single-arm, Single-center, Open Clinical Study
Where
Zhengzhou
Age
18 years to 75 years
People
10
Run by
Beijing Geekgene Technology Co., LTD
See details and how to joinNCT06431100
No phaseTaking people
Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery
Where
Guangzhou
Age
18 years and over
People
150
Run by
The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06420427
No phaseTaking people
Cervical Cancer Susceptible Population Classification
Where
Hefei
Age
18 years and over
People
10,000
Run by
Anhui Provincial Hospital
See details and how to joinNCT06405945
No phaseTaking people
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Where
Mianyang, Yangchun
Age
9 years to 45 years
People
600
Run by
Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT05371353
No phaseNot yet taking people in China
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Where
Fuzhou
Age
20 years to 85 years
People
200
Run by
Fujian Cancer Hospital
See details and how to joinNCT06197126
No phaseNot yet taking people in China
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
Where
Fuzhou
Age
13 years to 14 years
People
3,000
Run by
Fujian Maternity and Child Health Hospital
See details and how to joinNCT06137352
No phaseNot yet taking people in China
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Where
Fuzhou
Age
20 years to 85 years
People
500
Run by
Fujian Cancer Hospital
See details and how to joinNCT06101966
No phaseTaking people
Radiomics-based Malnutrition for Cervical Cancer.
Where
Hangzhou
Age
18 years to 80 years
People
150
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT05709769
No phaseTaking people
Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
Where
Guiyang
Age
18 years to 75 years
People
30
Run by
Guizhou Provincial People's Hospital
See details and how to joinNCT05950087
No phaseTaking people
Retrospective Study of Brachytherapy
Where
Hangzhou
Age
18 years to 80 years
People
300
Run by
Zhejiang Cancer Hospital
See details and how to joinNCT05242861